NEWS | July 9, 2015

Rogawski receives 2015 Neuroendocrine Research Award from the American Academy of Neurology

(SACRAMENTO, Calif.)

Michael Rogawski, professor of neurology at UC Davis, recently was awarded the 2015 Neuroendocrine Research Award at the 67th Annual American Academy of Neurology meeting in Washington, D.C.

Michael Rogawski Michael Rogawski

Rogawski is internationally renowned as an innovative thinker on the development of treatments for neurological disorders, including epilepsy, migraine, traumatic brain injury and neurobehavioral disorders. He was honored in recognition of his research on neurosteroids in the treatment of neurological disorders. Rogawski is a leading expert on epilepsy therapeutics. He was among the first to investigate neurosteroids as a treatment approach.

“Dr. Rogawski was chosen to receive the American Academy of Neurology Neuroendocrine Award this year from a competitive field of candidates due to his outstanding contributions in translational research in neurosteroids," said Cynthia Harden, chair of the award committee and professor of neurology, Hofstra North Shore–Long Island Jewish School of Medicine.

"Among his many areas of expertise, he has pioneered the understanding of the mechanism of allopregnanolone in modulating neuronal excitability, and has been visionary in piloting its use in persons with refractory seizures. He is truly an example of how a gifted investigator can impact an entire field, as well as individual lives to advance care. This is a rare person, and he is most deserving of recognition through this award,” Harden said.

Prior to coming to UC Davis in 2006, Rogawski held the position of senior investigator and chief of the Epilepsy Research Section of the National Institute of Neurological Disorders and Stroke. Among his many honors, Rogawski has received the Epilepsy Research Award from the American Society for Pharmacology and Experimental Therapeutics. He recently completed a two-year term as president of the American Society for Experimental NeuroTherapeutics.

Rogawski received a Bachelor of Arts degree in biophysics from Amherst College and his medical doctorate and doctorate degrees in pharmacology from Yale University.

In addition to his research activities, Rogawski teaches at the UC Davis School of Medicine and cares for patients at the UC Davis Medical Center.

The Neuroendocrine Research Award is sponsored by the American Academy of Neurology and is supported by the friends of Dr. Andrew Herzog, chief of the Neuroendocrine Unit at Beth Israel Deaconess Medical Center and professor of neurology at Harvard Medical School. It comes with a certificate of recognition and a $500 prize. The award was presented April 27.

For more information, visit UC Davis School of Medicine at medschool.ucdavis.edu.